Taken together, our findings support the view that mtDNA deletions and elevated GDF-15 act as complementary markers of multisystem involvement in insulin-resistant conditions, reflecting the complex endocrine, immune, and neurovegetative phenotypes of IR, PCOS, and POI. This evidence concerns the gene INS and polycystic ovary syndrome.